The growing interest in successful weight management has led to considerable exploration into novel treatments. Currently, Retatrutide, a twin-action hormone and glucagon-like peptide-1 (GLP-1) receptor stimulator, has shown encouraging results in patient trials, implying potential for substantial weight reduction . Consequently , many individuals